Video |

XDR-TB patient successfully completes treatment

 

Late 2013, Elizabeth started treatment for multidrug-resistant tuberculosis (MDR-TB) at MSF’s Green House Clinic in Nairobi. Five months later, treatment was not having any effect and she was diagnosed with a more severe form of the disease, extensively drug-resistant tuberculosis (XDR-TB). Elizabeth’s new treatment included Bedaquiline. She was the first patient in Kenya to receive this new anti-TB drug. Her treatment lasted 24 months.

How is it possible...

...that we sent people to the moon almost 50 years ago, yet millions of people with tuberculosis are still treated with old, inadequate medicines?